A lot of valuations are based on future earnings, which may not materialize assuming the contract does not proceed as planned. It\'s always better to proceed with caution and be conservative. Wait for the earnings to appear and for the Balance Sheet to show strength before investing. For companies which are just venturing into a new business (this company used to be Nylect), it pays to be prudent in assessing their chances of success. Just my 2-cents.
amazingly, DBS Vickers has recently initiated coverage of Ezion with a target price of $0.76! maybe hv to look closely at this stock to understand it better. Another Ezra?
